The role of quantitative T1 and T2 mapping for detecting minimal hepatic encephalopathy in chronic hepatic schistosomiasis patients
Authors:
Open Access
- 6 January 2026
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (1) , e0339588
Abstract
Background: Minimal hepatic encephalopathy (MHE) is a frequent neurocognitive complication in chronic hepatic schistosomiasis (CHS) patients. Conventional diagnostic tools are time-consuming and influenced by education level. Quantitative MRI mapping offers a potential non-invasive biomarker for MHE, but its role in CHS remains unclear. Aim: This study aimed to evaluate the diagnostic value of quantitative T1 and T2 mapping for detecting MHE in CHS patients. Methods: This prospective cross-sectional observational study was conducted from August 2023 to July 2024. A total of 88 CHS patients were enrolled and divided into MHE (n = 50) and non-MHE group (n = 38). MHE was assessed using the number connection test-A (NCT-A) and digit symbol test (DST). All participants underwent 3.0T MRI with T1 and T2 mapping. Group comparisons, correlation analyses, logistic regression, and receiver operating characteristic (ROC) curve analyses were performed. Results: MHE patients exhibited significantly lower T1 values across multiple brain regions, particularly the globus pallidus (all p < 0.001). T2 values showed no significant differences between groups. Multivariable regression confirmed that lower T1 values were independently associated with MHE (p = 0.009). ROC analysis demonstrated excellent diagnostic performance of globus pallidus T1 values (AUC = 0.92, 95% CI: 0.86–0.99), with sensitivity of 0.97 and specificity of 0.90. T1 values were also correlated with neuropsychological tests (NCT-A: r = −0.345, p < 0.001; DST: r = 0.232, p = 0.029). However, T2 values showed no significant group differences or diagnostic value. Conclusion: Quantitative T1 mapping, rather than T2 mapping, could be used as a potential non-invasive biomarker for detecting MHE in CHS patients. This approach offers an objective complement to psychometric testing and may facilitate earlier diagnosis and monitoring of MHE progression.Keywords
Funding Information
- Shanghai Jinshan District Science and Technology Committee (2023-WS-07)
- Jinshan District Health Commission (JSZK2023A02)
- Jinshan Hospital (KYQDJJ202501)
This publication has 24 references indexed in Scilit:
- Brain magnetic resonance imaging radiomics features associated with hepatic encephalopathy in adult cirrhotic patientsNeuroradiology, 2022
- MR T1 mapping for quantifying brain manganese deposition in type C hepatic encephalopathy ratsBioMetals, 2021
- Contributions and achievements on schistosomiasis control and elimination in China by NIPD-CTDRAdvances in Parasitology, 2020
- Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life IssuesDrugs, 2019
- Basal ganglia hyperintensity may be a marker of hepatic encephalopathy secondary to portosystemic shuntingClinics and Research in Hepatology and Gastroenterology, 2015
- Elevated dopamine induces minimal hepatic encephalopathy by activation of astrocytic NADPH oxidase and astrocytic protein tyrosine nitrationThe International Journal of Biochemistry & Cell Biology, 2014
- T2* MRI of minimal hepatic encephalopathy and cognitive correlates in vivoJournal of Magnetic Resonance Imaging, 2012
- Magnetic resonance T2‐relaxometry and 2D L‐correlated spectroscopy in patients with minimal hepatic encephalopathyJournal of Magnetic Resonance Imaging, 2009
- Temporal changes in the T1 and T2 relaxation rates (ΔR1 and ΔR2) in the rat brain are consistent with the tissue‐clearance rates of elemental manganeseMagnetic Resonance in Medicine, 2009
- Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathyMetabolic Brain Disease, 1995